Tyrosine Kinase Inhibitors: A Potential Approach to the Treatment of Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|32|3301-3304

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.32, 2007-11, pp. : 3301-3304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Inhibitors: Potential for the Treatment of Primary Brain Tumours

By DeMattia J.A.   Zhang W.   Couldwell W.T.  

CNS Drugs, Vol. 12, Iss. 6, 1999-12 ,pp. : 421-430

Adis International

Access to resources Recommend Favorite

Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 300-312

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-03 ,pp. : 760-773

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes

By Prada Patricia O  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 751-763

Informa Healthcare

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors in cancer treatment

By Traxler P.M.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. : 571-588

Informa Healthcare

Access to resources Recommend Favorite